The store will not work correctly when cookies are disabled.
2-(4-phenylphenyl)sulfonylisoindoline-1,3-dione
ID: ALA4855650
PubChem CID: 164613520
Max Phase: Preclinical
Molecular Formula: C20H13NO4S
Molecular Weight: 363.39
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1c2ccccc2C(=O)N1S(=O)(=O)c1ccc(-c2ccccc2)cc1
Standard InChI: InChI=1S/C20H13NO4S/c22-19-17-8-4-5-9-18(17)20(23)21(19)26(24,25)16-12-10-15(11-13-16)14-6-2-1-3-7-14/h1-13H
Standard InChI Key: GWMPMXHLDRQVMG-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
13.7148 -7.6271 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9294 -8.4195 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.5084 -7.8375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8976 -9.4514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1519 -8.6747 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4890 -8.1925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4877 -7.3754 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.3771 -10.1131 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.5360 -8.9709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3595 -9.7700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9653 -10.3211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7471 -10.0716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9196 -9.2659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3124 -8.7183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3509 -10.6190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1768 -11.4185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7815 -11.9671 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5605 -11.7173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7314 -10.9139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1254 -10.3688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0817 -9.4510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8293 -8.6718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0298 -8.5021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4820 -9.1107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7392 -9.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5380 -10.0577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
21 4 1 0
4 5 1 0
5 6 1 0
6 22 1 0
6 7 2 0
4 8 2 0
5 2 1 0
2 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
12 15 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 363.39 | Molecular Weight (Monoisotopic): 363.0565 | AlogP: 3.34 | #Rotatable Bonds: 3 |
Polar Surface Area: 71.52 | Molecular Species: ┄ | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.94 | CX LogD: 3.94 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.67 | Np Likeness Score: -0.71 |
References
1. Parsons WH, Rutland NT, Crainic JA, Cardozo JM, Chow AS, Andrews CL, Sheehan BK.. (2021) Development of succinimide-based inhibitors for the mitochondrial rhomboid protease PARL., 49 [PMID:34311087] [10.1016/j.bmcl.2021.128290] |